solitary fibrous tumour
Recently Published Documents


TOTAL DOCUMENTS

395
(FIVE YEARS 66)

H-INDEX

28
(FIVE YEARS 4)

Author(s):  
Alba Correa Bonito ◽  
Patricia Muñoz-Hernández ◽  
Ángela de la Hoz Rodríguez ◽  
Jesús Delgado Valdueza ◽  
Elena Martín Pérez

Cureus ◽  
2021 ◽  
Author(s):  
Rahul Pankhania ◽  
Yu Lau ◽  
Gentle Wong ◽  
San Sunkaraneni

2021 ◽  
pp. 103032
Author(s):  
Nurul Anis Mohd Fauzi ◽  
Noor Idayu Ibrahim ◽  
Wan Faiziah Wan Abdul Rahman ◽  
Sharifah Emilia Tuan Sharif ◽  
Muhammad Nasri Abu Bakar ◽  
...  

2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Arshi Beg ◽  
Jeenal Parikh ◽  
Amit Janu ◽  
Rajiv Kumar Kaushal

Abstract Background Malignant Solitary fibrous tumour (SFT) is an uncommon mesenchymal tumour with aggressive clinical behaviour as compared to its benign counterpart. There are only a handful of reports of extra-pleural malignant SFT arising from the mediastinum. Case presentation A 68-year-old male, presented with a history of cough and breathlessness for 2 weeks. Computed tomography (CT) scan revealed a large 11.6 × 11.3x18cm anterior mediastinal mass with extension to right hemithorax. The patient underwent excision of the mass after a biopsy confirmation of mesenchymal tumour. Histological examination of resection specimen revealed a spindle cell tumour with hypo and hypercellular areas, arranged in fascicular, focal storiform and hemangio-pericytomatous vasculature pattern. Moderate to marked nuclear atypia, frequent mitosis and areas of necrosis were noted. On immunohistochemistry (IHC), the tumour cells were positive for CD34, Bcl2, MIC2 (dot-like) and focally for S100 and Desmin. Although, the possibility of a malignant peripheral nerve sheath tumour with heterologous rhadomyosarcomatous differentiation (Triton tumour) was considered, however IHC for STAT6 confirmed it to be a malignant SFT. The patient developed recurrence within 1 year after surgery and despite multi-modality treatment (Re-excision, Chemotherapy and Radiotherapy) succumbed within 14 months from point of presentation. Conclusion Malignant SFT is a rare aggressive tumour that should be considered as a differential diagnosis in the mediastinum and a broad panel of IHC markers including STAT6 may be required to confirm the diagnosis.


2021 ◽  
Vol 14 (10) ◽  
pp. e244603
Author(s):  
Swaminathan Perinkulam Sathyanarayanan ◽  
Khizar Hamid ◽  
Kayla Hoerschgen ◽  
Tony Oliver

Solitary fibrous tumours (SFTs) are rare mesenchymal tumours that are mostly seen in the pleura. Lately, they have also been described in other locations. Recent discovery of the NAB2-STAT6 fusion gene which is specific for SFTs has led to an accurate diagnosis of SFTs. The occurrence of SFTs in the mesentery is very rarely reported in the literature. We report a case of a 63-year-old female who presented with abdominal pain, rectal bleeding and Fusobacterium bacteraemia, who was ultimately found to have a mesenteric SFT.


2021 ◽  
Vol 16 (10) ◽  
pp. S1063
Author(s):  
S. Ricciardi ◽  
N. Daddi ◽  
G. Tallini ◽  
G. Dolci ◽  
F. Antonacci ◽  
...  

2021 ◽  
Vol 8 (9) ◽  
pp. 2830
Author(s):  
Sayanna S. Shengulwar ◽  
Prasad K. R. K. ◽  
Swarnalatha S. ◽  
Purendar Reddy P. ◽  
Prapul Chandra Reddy E. ◽  
...  

Although giant solitary fibrous tumor is a rare soft tissue tumor but is to be considered in the differential diagnosis of benign breast tumors like fibroadenoma and phyllodes tumor at the time of clinical evaluation.


2021 ◽  
pp. 1-4
Author(s):  
Jan Roman ◽  
Petr Vávra ◽  
Michaela Vávrová ◽  
Vladimír Židlík ◽  
Anton Pelikán

Sign in / Sign up

Export Citation Format

Share Document